Related Experiment Video
Updated: May 7, 2026

Embolic Middle Cerebral Artery Occlusion MCAO for Ischemic Stroke with Homologous Blood Clots in Rats
Published on: September 17, 2014
Oral microbiome dysbiosis in cryptogenic ischemic stroke patients with high-risk patent foramen ovale
Muhammed Manzoor1, Jaakko Leskelä2, Milla Pietiäinen2,3
1Department of Oral and Maxillofacial Diseases, University of Helsinki, PO Box 63, 00014, Helsinki, Finland. muhammed.allippara@helsinki.fi.
Abstract:
Patent foramen ovale (PFO) is the most common congenital heart abnormality of foetal origin and has been associated with cryptogenic ischemic stroke (CIS) through several mechanisms, with most theories supporting paradoxical embolism. Other possible but unknown contributing factors, such as the role of the microbiome in PFO-associated strokes, remain unclear. We analysed saliva metagenomes to study the differences in the oral microbiome between young-onset CIS patients with clinically relevant high-risk PFO (n = 52) and those without PFO (n = 52). Age- and sex-matched stroke-free controls (n = 16) with high-risk PFO were included for the comparison. Beta diversity was significantly different between patients and controls with high-risk PFO, but not between patients with and without high-risk PFO. The phylum Ascomycota and class Saccharomycetes were significantly more abundant in patients with high-risk PFO than in those without high-risk PFO. Additionally, the abundance of Lactococcus, including Lactococcus raffinolactis and L. cremoris, was higher in controls with high-risk PFO than in patients with high-risk PFO. These findings highlight that oral dysbiosis and high-risk PFO may form a critical but under-recognized combination in the aetiology of CIS. Future research should focus on elucidating the precise mechanisms of these interactions and developing targeted interventions.
Insights
Patent foramen ovale (PFO), a common heart defect, is linked to cryptogenic ischemic stroke (CIS). Oral microbiome differences were found in CIS patients with high-risk PFO, suggesting a potential role in stroke development.
Area of Science:
- Cardiology
- Neurology
- Microbiome Research
Background:
- Patent foramen ovale (PFO) is the most common congenital heart defect, often linked to cryptogenic ischemic stroke (CIS) via paradoxical embolism.
- The role of the oral microbiome in PFO-associated CIS remains unclear, representing a gap in understanding stroke etiology.
Purpose of the Study:
- To investigate differences in the oral microbiome between young-onset CIS patients with and without high-risk PFO.
- To compare oral microbiomes of stroke patients with high-risk PFO to stroke-free controls with high-risk PFO.
Main Methods:
- Saliva metagenomes were analyzed from young-onset CIS patients with high-risk PFO (n=52) and without PFO (n=52).
- Age- and sex-matched stroke-free controls with high-risk PFO (n=16) were included for comparison.
- Beta diversity analysis was performed to assess microbial community differences.
Main Results:
- Significant differences in oral microbiome beta diversity were observed between patients with high-risk PFO and controls with high-risk PFO.
- The phylum Ascomycota and class Saccharomycetes were more abundant in CIS patients with high-risk PFO compared to those without PFO.
- Lactococcus abundance, including L. raffinolactis and L. cremoris, was higher in stroke-free controls with high-risk PFO than in CIS patients with high-risk PFO.
Conclusions:
- Oral dysbiosis, characterized by specific microbial shifts, may be associated with patent foramen ovale in cryptogenic ischemic stroke.
- The interplay between high-risk PFO and oral microbiome alterations presents a potential, under-recognized factor in CIS etiology.
- Further research is needed to clarify the mechanisms and develop targeted interventions for PFO-associated CIS.
Related Concept Videos
The Oral Microbiota
Development of the Oral Microbiota
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

